Valeo Financial Advisors, LLC Biomarin Pharmaceutical Inc Transaction History

Valeo Financial Advisors, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$75.51 - $84.79 $311,327 - $349,589	-4,123 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$74.73 - $90.69 $11,209 - $13,603	-150 Reduced 3.51%	4,123 $311,000
Q4 2020 Feb 11, 2021	BUY	$72.61 - $90.2 $263,066 - $326,794	3,623 Added 557.38%	4,273 $375,000
Q3 2020 Oct 28, 2020	BUY	$71.87 - $131.03 $6,827 - $12,447	95 Added 17.12%	650 $49,000
Q2 2020 Jul 20, 2020	SELL	$79.55 - $124.22 $31,422 - $49,066	-395 Reduced 41.58%	555 $68,000
Q1 2020 Apr 13, 2020	SELL	$71.37 - $96.85 $55,240 - $74,961	-774 Reduced 44.9%	950 $76,000
Q4 2019 Jan 24, 2020	BUY	$64.27 - $86.37 $32,134 - $43,185	500 Added 40.85%	1,724 $146,000
Q3 2019 Oct 15, 2019	BUY	$67.4 - $85.11 $404 - $510	6 Added 0.49%	1,224 $82,000
Q2 2019 Jul 10, 2019	BUY	$80.35 - $93.9 $96,420 - $112,680	1,200 Added 6666.67%	1,218 $104,000
Q1 2019 Apr 12, 2019	SELL	$84.2 - $98.62 $3,452 - $4,043	-41 Reduced 69.49%	18 $2,000
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $4,484 - $5,842	59 New	59 $6,000
Q1 2018 Apr 12, 2018	SELL	$77.67 - $92.63 $4,038 - $4,816	-52 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$80.76 - $95.13 $1,049 - $1,236	-13 Reduced 20.0%	52 $5,000
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $5,239 - $6,171	65	65 $6,000

638

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.